Home

Baxter International (BAX)

28.79
-2.56 (-8.17%)
NYSE · Last Trade: Apr 5th, 3:40 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to Baxter International (BAX)

Abbott Laboratories ABT -5.46%

Abbott Laboratories and Baxter International often find themselves in competition within the diagnostics and vascular products markets. Abbott has a robust product lineup that includes specialized diagnostics and an extensive range of cardiovascular care products, which allows it to offer comprehensive healthcare solutions to its clients. Although Baxter maintains its presence in these areas, Abbott's established reputation for innovation and reliability in diagnostics gives it a competitive advantage, particularly in the rapid testing and monitoring sectors.

Cardinal Health CAH -5.44%

Cardinal Health competes with Baxter International primarily in the distribution and supply chain management of medical products and pharmaceuticals. Both companies provide essential services to healthcare providers; however, Cardinal Health has a significant edge in logistics and distribution, leveraging its extensive network to efficiently deliver products. This advantage in logistics allows Cardinal Health to be a dominant player in the supply chain arena, making it a strong competitor to Baxter, especially in providing value-added services.

Fresenius Medical Care FMS -6.74%

Fresenius Medical Care and Baxter International are vital players in the renal care space, where they compete in the production of dialysis equipment and related services. While both companies have overlapping product offerings, Fresenius has a strong foothold in the dialysis market, with a focus on healthcare services that enhance patient outcomes. The company's integrated approach, combining product development with service delivery, offers it a competitive advantage over Baxter in the renal therapies segment.

Medtronic MDT -5.70%

Medtronic and Baxter International compete primarily in the medical technology and devices sector, focusing on similar product lines such as diabetes management and surgical products. Both companies aim to innovate in therapies and devices, but Medtronic has a notable competitive advantage in its comprehensive portfolio of cardiovascular and diabetes solutions, such as insulin pumps and continuous glucose monitoring systems. This breadth allows Medtronic to capture a larger market share, especially in critical care settings, positioning it as a formidable competitor in the healthcare industry.

Thermo Fisher Scientific TMO -6.83%

Thermo Fisher Scientific and Baxter International compete in the life sciences sector, delivering a range of products from laboratory equipment to biopharmaceutical services. Although their offerings differ, the two companies overlap in areas such as biotechnology development and diagnostics. Thermo Fisher's extensive focus on instrumentation and reagents provides it with a competitive edge due to its innovative product development and established presence in research laboratories, positioning it more favorably compared to Baxter's primary emphasis on therapeutic solutions.